Joseph Yanchik

Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.

Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA.

The Rockefeller Foundation operates and organizes charitable trusts. The company supports grants, fellowships, and conferences for programs that try to identify and alleviate need and suffering. It was founded in 1913 by John D. Rockefeller Sr. and is headquartered in New York City, NY.

Tusker Medical, Inc. engages in the development of medical devices for ear, nose, and throat treatments. It offers iontophoresis system and tube delivery system. The company is headquartered in Menlo Park, CA.

Gala Therapeutics, Inc. engages in biotech and pharma products. The company was founded in October 2015 by Jonathan Reuben Waldstreicher and is headquartered in San Carlos, CA.

Galavant Therapeutics, Inc. operates a biotechnology firm. The company is headquartered in Menlo Park, CA.

Galaxy Medical, Inc. provides biotechnology services. The company is headquartered in Menlo Park, CA.

Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY.

Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY.

Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA.

Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA.

Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Alameda, CA.

Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation.

Adendra Therapeutics Ltd. is an emerging British biotechnology company that was founded in 2021 as a spin-out of the Francis Crick Institute. The company is based in London, UK. The company is focused on discovering and developing new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases, building on new insights into dendritic cell biology. The company was founded in 2021 by Caetano Reis E Sousa, Raj Mehta. Raj Mehta has been the CEO since 2021.

Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023.

The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra.

Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut.

New York Studio School of Drawing Painting & Sculpture provides arts education services. It offers programs and courses where a student gets a certificate and master in fine arts degree. The company was founded on September 23, 1964 and is headquartered in New York, NY.

Sevin Rosen Bayless Management Co (Sevin Rosen Bayless) is a venture capital firm founded in 1981. The firm is headquartered in Dallas, Texas.

The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD.

Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands.

CleanSlate Centers, Inc. operates addiction treatment center. It offers drug treatment, alcohol treatment, and treatment for multiple addictions. The company was founded by Amanda Wilson in 2009 and is headquartered in Northampton, MA.

Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.

Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.

Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA.

Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA.

Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA.